Jong-Ho Cha

Oncology · 2016–2019

A researcher in the Science corpus: 4 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom Jong-Ho Cha trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Lieping Chen
  2. D. Pardoll
  3. Chia‐Wei Li
  4. C. V. Dang

Papers from Jong-Ho Cha's perspective

Ordered by how strongly the researchers Jong-Ho Cha trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma (Nature Medicine)
  2. The blockade of immune checkpoints in cancer immunotherapy (Nature Reviews. Cancer)
  3. Improved Survival with Ipilimumab in Patients with Metastatic Melanoma (New England Journal of Medicine)
  4. Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity (Nature Medicine)
  5. Programmed death ligand-1 expression in non-small cell lung cancer (Laboratory Investigation)
  6. Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target. (Proceedings of the National Academy of Sciences of the United States of America)
  7. Blockade of Programmed Death-1 Ligands on Dendritic Cells Enhances T Cell Activation and Cytokine Production 1 (Journal of Immunology)
  8. Metformin and reduced risk of cancer in diabetic patients (British medical journal)
  9. Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion (Nature Medicine)
  10. Role of AMP-activated protein kinase in mechanism of metformin action. (Journal of Clinical Investigation)

Their papers